NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 4XGN designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 4XGN_NAD_A_300 | 97% | 4% | 0.063 | 0.981 | 4.07 | 1.89 | 14 | 10 | 0 | 0 | 100% | 1 |
| 4XGN_NAD_E_300 | 97% | 5% | 0.064 | 0.976 | 3.79 | 1.92 | 9 | 11 | 0 | 0 | 100% | 1 |
| 4XGN_NAD_H_302 | 96% | 4% | 0.063 | 0.974 | 3.99 | 1.92 | 13 | 8 | 0 | 0 | 100% | 1 |
| 4XGN_NAD_C_301 | 95% | 5% | 0.068 | 0.973 | 3.75 | 1.7 | 11 | 8 | 0 | 0 | 100% | 1 |
| 4XGN_NAD_F_300 | 94% | 6% | 0.073 | 0.974 | 3.61 | 1.7 | 12 | 9 | 0 | 0 | 100% | 1 |
| 4XGN_NAD_D_302 | 94% | 4% | 0.074 | 0.974 | 4.07 | 1.75 | 9 | 12 | 0 | 0 | 100% | 1 |
| 4XGN_NAD_B_300 | 93% | 7% | 0.073 | 0.969 | 3.5 | 1.62 | 11 | 7 | 0 | 0 | 100% | 1 |
| 4XGN_NAD_G_302 | 93% | 6% | 0.074 | 0.97 | 3.76 | 1.62 | 11 | 7 | 1 | 0 | 100% | 1 |
| 4URF_NAD_A_1249 | 100% | 45% | 0.034 | 0.995 | 0.96 | 1.2 | 2 | 4 | 0 | 0 | 100% | 1 |
| 2C5A_NAD_B_1374 | 100% | 25% | 0.039 | 0.992 | 1.34 | 1.84 | 6 | 7 | 1 | 0 | 100% | 1 |
| 1HET_NAD_A_402 | 100% | 11% | 0.043 | 0.994 | 2.25 | 2.1 | 9 | 8 | 0 | 0 | 100% | 0.9068 |
| 2JHF_NAD_B_403 | 100% | 18% | 0.04 | 0.99 | 2.08 | 1.62 | 11 | 5 | 2 | 0 | 100% | 1 |
| 1HEU_NAD_B_402 | 100% | 8% | 0.043 | 0.993 | 2.5 | 2.41 | 13 | 11 | 0 | 0 | 100% | 0.8886 |
